Written and maintained by CASRAI Editorial Board
Last updated
A pressure injury prevention programme is the difference between a hospital that knows the evidence-based prevention elements and one that can prove, unit by unit, that those elements happened on every at-risk patient, every shift. This page is the programme layer: risk-screening cadence, the prevention bundle itself, how unit-based skin rounds are structured, and how the hospital-acquired pressure injury (HAPI) rate that comes out the other end feeds NDNQI nursing-sensitive-indicator reporting and the CMS HAC Reduction Program. It does not re-teach wound staging from first principles or the mechanics of the CAUTI/CLABSI-style surveillance definition — those live in the terminology note below and in the sibling guides linked throughout.
Terminology: pressure injury, not pressure ulcer
The National Pressure Injury Advisory Panel (NPIAP — known as the National Pressure Ulcer Advisory Panel, NPUAP, before a 2016 rename) moved the field’s vocabulary from "pressure ulcer" to "pressure injury" specifically because Stage 1 and Deep Tissue Pressure Injury involve intact skin with no open ulcer — "ulcer" described only the later stages accurately. The staging system in current clinical use is: Stage 1 (non-blanchable erythema of intact skin), Stage 2 (partial-thickness skin loss with exposed dermis), Stage 3 (full-thickness skin loss with visible fat), Stage 4 (full-thickness skin and tissue loss with exposed fascia, muscle, tendon, ligament, cartilage, or bone), Unstageable (full-thickness skin and tissue loss obscured by slough or eschar, so the true depth cannot be assessed), and Deep Tissue Pressure Injury (persistent non-blanchable deep red, maroon, or purple discoloration indicating damage to underlying soft tissue). A separate category, Medical Device-Related Pressure Injury, covers injury from the pressure of a device against skin (a nasal cannula, a pulse oximeter probe, a cervical collar) rather than from surface contact with a bed or chair — it is staged using the same system but tracked separately because the prevention response is device-specific, not surface-specific. This staging framework is standard, widely-taught wound-care terminology; it was not independently re-verified against a live NPIAP primary source this session (npiap.com returned HTTP 403 to an automated fetch) — treat it as REPORTED-tier and re-confirm directly against NPIAP’s current published definitions before using it in anything more load-bearing than the general orientation this page provides.
Risk screening: cadence, not just the tool
The Braden Scale (or, for pediatric units, the Braden Q) is the most widely used validated pressure-injury risk-assessment instrument in US hospitals, scoring six subscales — sensory perception, moisture, activity, mobility, nutrition, and friction/shear — to produce a composite score where lower values indicate higher risk. Neither CMS nor NDNQI mandates a specific instrument or a specific rescreening interval; what a programme actually needs to specify in policy, and what a surveyor or an internal audit checks, is the cadence: a baseline screen on admission, a rescreen at a fixed interval (commonly every shift in critical care and every 24 hours on medical-surgical units, though the exact interval is a hospital policy decision, not a federal number), and a mandatory rescreen on any significant change in condition — a new sedation order, an unplanned OR trip, a transfer to a higher level of care, or a new device placement. A screening tool used inconsistently, or used once at admission and never repeated, produces a false sense of coverage: the patient whose mobility declines on hospital day three is exactly the one a single admission screen misses.
The prevention bundle
Once a patient screens at risk, the bundle is the fixed set of interventions applied — not selected case by case from clinical judgment, the same logic that governs CAUTI and CLABSI bundles elsewhere in this cluster. The elements with the strongest evidence base are: a scheduled repositioning turn (commonly every two hours for a fully immobile patient, adjusted by support-surface capability and patient tolerance), pressure-redistributing support surfaces matched to risk level (from a standard foam mattress up to low-air-loss or alternating-pressure surfaces for the highest-risk patients), a structured skin inspection at every position change with particular attention to the sacrum, heels, occiput, and any area under a medical device, moisture management separating incontinence-associated skin damage from true pressure injury so the wrong intervention is not applied to the wrong problem, a nutrition consult for patients screening at risk (protein-calorie malnutrition is one of the Braden subscales for a reason), and heel offloading — heels carry disproportionate risk because they have almost no subcutaneous tissue over bone, and a dedicated offloading device is a distinct intervention from general repositioning, not a byproduct of it. As with any bundle, the programme value is in auditing whether each element actually happened and was documented, not in the existence of a policy stating that it should.
Unit-based skin rounds
Skin rounds are the operational mechanism that keeps the bundle from existing only on paper. A working programme runs them on a fixed schedule — commonly weekly on medical-surgical units and more frequently in critical care — as an interdisciplinary walk of every at-risk patient involving nursing, and depending on the hospital’s structure a wound-care nurse or skin champion. Each round produces three concrete outputs: a documented stage and location for any existing pressure injury (with photo documentation where hospital policy and consent permit it, since photographs are the most defensible record when a stage is later disputed), a documented decision on whether the current bundle assignment still matches the patient’s current risk level, and an escalation trigger — a defined threshold, such as any new Stage 2 or higher injury, or any injury that is not improving on schedule, that automatically routes to a wound-care specialist consult rather than waiting for the primary team to notice and order one.
The HAPI rate: what it measures and where it is reported
"HAPI rate" is not one single number; it surfaces in at least three separate reporting contexts a programme has to keep straight. First, as a nursing-sensitive indicator: pressure ulcer/injury prevalence was one of the original NQF-endorsed nursing-sensitive measures and remains part of the current NDNQI (Press Ganey-owned since the National Database of Nursing Quality Indicators transitioned from its original ANA stewardship) measure set used for unit-level benchmarking and, commonly, as supporting evidence in ANCC Magnet applications — though ANCC’s own eligibility criteria require organizations to benchmark nurse-sensitive indicators against a national database generally, not NDNQI by name. Second, as a federal quality measure: the Hospital Harm — Pressure Injury electronic clinical quality measure (CMS826v3) is part of the eCQM set hospitals report under the CMS Hospital Inpatient Quality Reporting program, and CMS’s FY 2027 IPPS final rule schedules it moving from a self-selected option toward mandatory reporting as the overall eCQM set expands in coming reporting years — see the HAC Reduction Program guide linked below for how a hospital-acquired condition like a Stage 3/4 or unstageable pressure injury can also affect Medicare payment through that separate program. Third, internally: most programmes track their own HAPI rate (hospital-acquired cases per patient days, or per admissions) as a run-chart metric independent of what any external body requires, precisely because internal improvement work needs a number that moves faster than an annual federal reporting cycle. Getting present-on-admission (POA) documentation right at intake is what keeps these three numbers honest — a pressure injury staged and documented as already present at admission is not hospital-acquired and should not count against the unit’s rate; the single most common way a HAPI rate gets inflated by a documentation gap rather than a real care failure is a missed or incomplete admission skin assessment.
Building the programme, not just the bundle
A durable programme needs an explicit governance owner — typically a nursing quality committee or a designated skin/wound champion structure reporting into it — responsible for three standing functions: reviewing the audit data from skin rounds and bundle-compliance checks on a fixed cadence, not just when a bad outcome prompts a look; routing every Stage 3, Stage 4, unstageable, or medical-device-related pressure injury to the hospital’s existing serious-event review process (many hospitals treat a Stage 3+ hospital-acquired pressure injury as an adverse event warranting root cause analysis, and several states separately require it as a reportable event under their own patient-safety statutes, so check state reporting requirements alongside internal policy); and keeping the risk-screening tool, the bundle protocol, and the skin-round checklist under a documented review cycle so the programme reflects current NPIAP guidance rather than whatever was in place when it was first written.
Frequently asked questions
What is the difference between a pressure ulcer and a pressure injury?
They describe the same clinical problem under different terminology. NPIAP (formerly NPUAP) changed the standard term from "pressure ulcer" to "pressure injury" in 2016 because two of the six stages — Stage 1 and Deep Tissue Pressure Injury — involve intact skin with no actual ulceration, so "ulcer" was not an accurate description across the full staging range. Current clinical, regulatory, and reporting language uses "pressure injury."
How often should a hospitalized patient be rescreened for pressure injury risk?
Neither CMS nor NDNQI sets a fixed federal interval — a hospital’s own policy sets the rescreening cadence, and it is what an internal audit or accreditation surveyor checks against actual documentation. Common patterns are every shift in critical care and every 24 hours on medical-surgical units, plus a mandatory rescreen on any significant change in a patient’s condition or care setting.
Does a hospital-acquired Stage 3 or 4 pressure injury affect Medicare payment?
It can. Pressure injuries at Stage 3 or higher are one of the hospital-acquired conditions relevant to CMS payment and quality-reporting programs, including the Hospital Harm — Pressure Injury eCQM and, depending on the specific measure and program year, the HAC Reduction Program — see the HAC Reduction Program guide linked below for how that scoring works.
What counts as a medical device-related pressure injury?
Injury caused by the pressure of a device — a nasal cannula, a pulse oximeter probe, a cervical collar, a non-invasive ventilation mask — against the skin, rather than from surface contact with a bed or chair surface. It is staged using the same NPIAP system as any other pressure injury but is tracked as its own category because the prevention response (device rotation, padding, sizing) is different from the general repositioning-and-support-surface bundle.
Related reading on this site: Nurse-Sensitive Indicators for where pressure ulcer/injury prevalence sits in the broader NQF-endorsed measure set; The HAC Reduction Program for how a hospital-acquired pressure injury factors into the total HAC score and the associated Medicare payment penalty; AHRQ Patient Safety Indicators Explained for how PSI-90 and related composite measures relate to hospital-acquired-condition reporting generally; CAUTI Prevention Bundle for a worked example of the same screen-bundle-audit programme structure applied to catheter-associated infection; and the Patient Safety pillar for the full cluster.
